Back
Vertex Pharmaceuticals Vs. AbbVie Industry Stock Comparison
Buy
58
VRTX
Vertex Pharmaceuticals
Last Price:
397.77
Seasonality Move:
11.79%
Sell
48
ABBV
AbbVie
Last Price:
167.25
Seasonality Move:
2.71%
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $397.70. The Score for VRTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $167.29. The Score for ABBV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $397.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
ABBV Stock Price Chart
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.14 | Sell |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | -107087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (396.36 - 413.98) | Sell |
| Bollinger Bands (100): | (390.37 - 431.87) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.41 | Sell |
| Relative Strength Index (14 RSI): | 43 | Sell |
| Chaikin Money Flow: | -409994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (164.81 - 177.87) | Sell |
| Bollinger Bands (100): | (157.22 - 177.76) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 397.26 | Buy |
| 20-day SMA: | 402.29 | Sell |
| 50-day SMA: | 412.15 | Sell |
| 200-day SMA: | 383.29 | Buy |
| 8-day EMA: | 399.01 | Sell |
| 20-day EMA: | 402.12 | Sell |
| 50-day EMA: | 407.64 | Sell |
| 200-day EMA: | 385.72 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.3 | Buy |
| 20-day SMA: | 169.48 | Sell |
| 50-day SMA: | 174.78 | Sell |
| 200-day SMA: | 156.69 | Buy |
| 8-day EMA: | 167.21 | Buy |
| 20-day EMA: | 169.15 | Sell |
| 50-day EMA: | 170.8 | Sell |
| 200-day EMA: | 160.73 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.29 per share, an increase this year of $1.64 per share, and an increase next year of $1.39 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.19 per share, a decrease this year of $0.01 per share, and an increase next year of $1.00 per share.
Vertex Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||